Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Menon Renewable Products is a private U.S. animal health and agricultural technology company focused on sustainable functional feed ingredients for aquaculture and livestock. Its lead commercial product family, MrFeed®, is produced using the company's proprietary Celtherm™ hydrocarbon conversion process and is designed to replace less sustainable feed inputs such as fish meal, poultry meal, soymeal, soy protein isolate, and SPC. The company positions MrFeed® as a functional ingredient that can improve digestibility, survivability, growth, and gut health while reducing reliance on antibiotics and lowering environmental pressure on conventional feed inputs. Menon also highlights external validation and commercial use of its products in aquaculture, poultry, shrimp, and other animal nutrition applications worldwide. In addition to feed products, the company has disclosed nutraceutical work in humans, including a study in type 2 diabetes and hyperlipidemia, but its core business appears to be commercial animal feed technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Menon Renewable Products.